Literature DB >> 28949840

Adolescent oncofertility discussions: Recommendations from a systematic literature review.

Dorit Barlevy1, Bernice S Elger1, Tenzin Wangmo1, Vardit Ravitsky2.   

Abstract

BACKGROUND: Increasing cancer incidence and survivorship rates have made late-term effects, such as effects on fertility, a salient issue for adolescent cancer patients. While various barriers make it difficult for health care professionals to discuss oncofertility with adolescents and their parents, there are numerous reasons to hold such discussions, based on professional obligations and the ethical principles of respect for autonomy and beneficence. This systematic literature review presents and critically examines recommendations for adolescent oncofertility discussions.
METHODS: Conducted according to PRISMA guidelines, this systematic literature review includes English, French, and German articles published up until December 31, 2014. Articles were sought via a combination of search terms in four databases.
RESULTS: Eighty of 96 articles included in this review address recommendations for improving adolescent oncofertility discussions. These recommendations deal with how, when, what, and with whom professionals ought to have these discussions, as well as various systemic barriers and ways to address them.
CONCLUSIONS: Based upon the principles of beneficence, respect for autonomy, and justice, we endorse several recommendations for oncofertility discussions with adolescents and their parents, including having a specific professional on the health care team initiate these discussions with all newly diagnosed patients; regularly doing so before, during, and after treatment; allowing adolescents to decide for themselves whom they wish to include in such discussions; employing various forms of communication; obtaining both adolescent assent and parental consent for fertility preservation (FP) procedures, especially at each stage (e.g., procurement and use); properly educating and training professionals to discuss oncofertility; promoting interdisciplinary collaboration; creating and implementing guidelines and policies; and ensuring equity of access to FP.

Entities:  

Keywords:  adolescent; discussion; fertility preservation; oncofertility; recommendations

Mesh:

Year:  2017        PMID: 28949840     DOI: 10.1080/23294515.2017.1305006

Source DB:  PubMed          Journal:  AJOB Empir Bioeth        ISSN: 2329-4515


  5 in total

1.  Accurate understanding of infertility risk among families of adolescent males newly diagnosed with cancer.

Authors:  Vicky Lehmann; Jessica S Flynn; Rebecca H Foster; Kathryn M Russell; James L Klosky
Journal:  Psychooncology       Date:  2018-02-20       Impact factor: 3.894

Review 2.  Evaluation of Patient-Reported Outcome Measures of Positive Psychosocial Constructs in Children and Adolescent/Young Adults with Cancer: A Systematic Review of Measurement Properties.

Authors:  Cole Wayant; Kaylea Bixler; Morgan Garrett; Jennifer W Mack; Drew Wright; Matt Vassar
Journal:  J Adolesc Young Adult Oncol       Date:  2021-05-13       Impact factor: 2.223

3.  Family communication about fertility preservation in adolescent males newly diagnosed with cancer.

Authors:  Anna L Olsavsky; Charleen I Theroux; Taylor M Dattilo; James L Klosky; Sarah H O'Brien; Gwendolyn P Quinn; Cynthia A Gerhardt; Leena Nahata
Journal:  Pediatr Blood Cancer       Date:  2021-02-25       Impact factor: 3.838

4.  A Reliability Generalization Meta-Analysis of 17 Patient-Reported Outcome Measures for Positive Psychosocial Constructs in Children, Adolescents, and Young Adults with Cancer.

Authors:  Cole Wayant; Morgan Garrett; Kaylea Bixler; Jennifer Mack; Jon Goodell; Matt Vassar
Journal:  J Adolesc Young Adult Oncol       Date:  2021-07-23       Impact factor: 1.757

5.  Impact of legislation and public funding on oncofertility: a survey of Canadian, French and Moroccan pediatric hematologists/oncologists.

Authors:  Aliya Oulaya Affdal; Michael Grynberg; Laila Hessissen; Vardit Ravitsky
Journal:  BMC Med Ethics       Date:  2020-04-03       Impact factor: 2.652

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.